By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aduro Biotech 

626 Bancroft Way
Suite 3C
Berkeley  California  94710  U.S.A.
Phone: 510-848-4400 Fax: n/a




Company News
Aduro Biotech (ADRO) Announces Second Quarter 2015 Financial Results 8/11/2015 10:24:35 AM
Aduro Biotech (ADRO) Completes Enrollment In Phase 1b Clinical Trial Of CRS-207 Immunotherapy For The Treatment Of Mesothelioma 8/10/2015 7:55:00 AM
Aduro Biotech (ADRO) To Present At The 35th Annual Canaccord Genuity Growth Conference 8/7/2015 6:15:17 AM
Aduro Biotech (ADRO) Announces Immunotherapy Regimen Successfully Passes Futility Analysis In Phase IIb ECLIPSE Trial In Metastatic Pancreatic Cancer 6/29/2015 7:28:48 AM
Aduro Biotech (ADRO) Appoints Industry Veteran, Stephen Sherwin, M.D., To Its Board Of Directors 6/26/2015 7:26:08 AM
Aduro Biotech (ADRO) Appoints Liana Wu As Vice President Of Commercia 6/2/2015 7:36:39 AM
ASCO15: Aduro Biotech (ADRO) Announces ASCO Presentation Of Encouraging Data From Ongoing Phase Ib Clinical Trial Of Its Immunotherapy For The Treatment Of Mesothelioma 6/1/2015 8:55:01 AM
Aduro Biotech (ADRO) To Present At Bank of America (BAC) Merrill Lynch 2015 Health Care Conference 5/7/2015 12:21:23 PM
Aduro Biotech (ADRO)'s Preclinical Results For Its STING-Targeted CDN Immuno-Oncology Platform Highlighted In Prestigious Peer-Reviewed Publications 5/7/2015 11:45:07 AM
How Aduro Biotech (ADRO)'s IPO Debut Could Tell Us A Lot About The So-Called "Biotech Bubble" 4/16/2015 6:59:50 AM